Satellite Symposium - Building confidence through long-term experience with fingolimod
ECTRIMS Learn. Presenters F. 09/15/16; 147375; 305
Faculty / Presenters
Abstract
Chairs
X. Montalban, Barcelona, Spain
H.-P. Hartung, Düsseldorf, Germany
supported by Novartis
Presentations
121a - Chair’s opening and welcome
H.-P. Hartung, Düsseldorf, Germany
13:00 – 13:03
121 - Building confidence in MS: long-term experience with fingolimod
B. Singer, St. Louis, United States
13:03 – 13:21
122 - Predictive analysis in MS disease monitoring: from clinical assessment to quantitative outcomes
X. Montalban, Barcelona, Spain
13:21 – 13:39
123 - Patient management in MS: the importance of acting early and effectively
H.-P. Hartung, Düsseldorf, Germany
13:39 – 13:57
123a - Closing remarks
X. Montalban, Barcelona, Spain
13:57 – 14:00
X. Montalban, Barcelona, Spain
H.-P. Hartung, Düsseldorf, Germany
supported by Novartis
Presentations
121a - Chair’s opening and welcome
H.-P. Hartung, Düsseldorf, Germany
13:00 – 13:03
121 - Building confidence in MS: long-term experience with fingolimod
B. Singer, St. Louis, United States
13:03 – 13:21
122 - Predictive analysis in MS disease monitoring: from clinical assessment to quantitative outcomes
X. Montalban, Barcelona, Spain
13:21 – 13:39
123 - Patient management in MS: the importance of acting early and effectively
H.-P. Hartung, Düsseldorf, Germany
13:39 – 13:57
123a - Closing remarks
X. Montalban, Barcelona, Spain
13:57 – 14:00
Chairs
X. Montalban, Barcelona, Spain
H.-P. Hartung, Düsseldorf, Germany
supported by Novartis
Presentations
121a - Chair’s opening and welcome
H.-P. Hartung, Düsseldorf, Germany
13:00 – 13:03
121 - Building confidence in MS: long-term experience with fingolimod
B. Singer, St. Louis, United States
13:03 – 13:21
122 - Predictive analysis in MS disease monitoring: from clinical assessment to quantitative outcomes
X. Montalban, Barcelona, Spain
13:21 – 13:39
123 - Patient management in MS: the importance of acting early and effectively
H.-P. Hartung, Düsseldorf, Germany
13:39 – 13:57
123a - Closing remarks
X. Montalban, Barcelona, Spain
13:57 – 14:00
X. Montalban, Barcelona, Spain
H.-P. Hartung, Düsseldorf, Germany
supported by Novartis
Presentations
121a - Chair’s opening and welcome
H.-P. Hartung, Düsseldorf, Germany
13:00 – 13:03
121 - Building confidence in MS: long-term experience with fingolimod
B. Singer, St. Louis, United States
13:03 – 13:21
122 - Predictive analysis in MS disease monitoring: from clinical assessment to quantitative outcomes
X. Montalban, Barcelona, Spain
13:21 – 13:39
123 - Patient management in MS: the importance of acting early and effectively
H.-P. Hartung, Düsseldorf, Germany
13:39 – 13:57
123a - Closing remarks
X. Montalban, Barcelona, Spain
13:57 – 14:00
{{ help_message }}
{{filter}}